Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1

Status

Completed 23Terminated 7Recruiting 3Unknown 2Active not recruiting 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 33Myelodysplastic Syndromes 9Recurrence 7Lymphoma, Large B-Cell, Diffuse 5Hodgkin Disease 5Lymphoma, Non-Hodgkin 2Leukemia, Myelomonocytic, Chronic 2Leukemia 2Wilms Tumor 1TP53 1Refractory or Relapsed Aggressive r/r B-NHL With Huge Tumor Burden 1Primary Malignant Neoplasm of Ovary 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Peripheral Blood Stem Cell Transplantation 1Pathologic Complete Response 1Pancreatic Neoplasms 1Neoplasms 1Neoplasm, Residual 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Malignant Solid Tumor 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid 1Hematopoietic System--Cancer 1Graft vs Host Disease 1Extranodal Extension 1Esophageal Squamous Cell Carcinoma 1

Interventions

Cytarabine 35Cyclophosphamide 26Etoposide 18Radiotherapy 16Daunorubicin 16Busulfan 15Peripheral Blood Stem Cell Transplantation 14Methotrexate 14Idarubicin 14Mercaptopurine 12Dexamethasone 12Vincristine 11Thioguanine 9Mitoxantrone 9Doxorubicin 8Asparaginase 8Antilymphocyte Serum 8pegaspargase 7fludarabine phosphate 7Prednisolone 7Polymerase Chain Reaction 7Filgrastim 7Cyclosporine 7Prednisone 6Mycophenolic Acid 5Melphalan 5Leucovorin 5Gene Expression Profiling 5Vindesine 4N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Leukemia × Decitabine × Clear all
NCT03799224 2019-05-29

Decitabine Plus mBU/CY Preconditioning for Relapse/Refractory Acute Leukemia

Peking University People's Hospital

Phase 2/3 Unknown
55 enrolled
Other hematologic neoplasm

Leukemia

NCT00043134 2010-04-13

Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic Syndrome

National Cancer Institute (NCI)

Phase 3 Unknown
220 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡